Related Experiment Video

Updated: Jun 11, 2026

Visualization of Endoplasmic Reticulum Localized mRNAs in Mammalian Cells
10:24

Visualization of Endoplasmic Reticulum Localized mRNAs in Mammalian Cells

Published on: December 17, 2012

Changes of the smooth endoplasmic reticulum induced by rifampicin in human and guinea-pig hepatocytes

A M Jezequel, F Orlandi, L T Tenconi

    Gut
    |December 1, 1971
    PubMed

    Insights

    Rifampicin causes smooth endoplasmic reticulum proliferation in liver cells, potentially boosting drug metabolism. However, differences between guinea pig and human cells highlight the need for caution when extrapolating animal study findings to humans.

    Area of Science:

    • Hepatology
    • Pharmacology
    • Cell Biology

    Background:

    • Rifampicin is known to affect liver cell function.
    • The smooth endoplasmic reticulum (SER) plays a crucial role in drug metabolism.
    • Understanding SER proliferation is key to understanding drug-induced liver effects.

    Purpose of the Study:

    • To investigate the effect of rifampicin on smooth endoplasmic reticulum (SER) proliferation in hepatocytes.
    • To compare SER proliferation patterns in human and guinea-pig hepatocytes.
    • To assess the implications for studying drug metabolism and enzyme induction.

    Main Methods:

    • Primary hepatocyte cultures from guinea pigs and humans were treated with rifampicin.
    • Electron microscopy was used to examine the ultrastructure of hepatocytes.
    • Quantification of SER proliferation was performed.

    Main Results:

    • Rifampicin induced significant proliferation of the SER in both guinea-pig and human hepatocytes.
    • The pattern and extent of SER proliferation differed between human and guinea-pig hepatocytes.
    • These findings suggest species-specific responses to rifampicin.

    Conclusions:

    • Rifampicin-induced SER proliferation supports its role in enhancing drug-metabolizing enzymes.
    • Species differences in SER proliferation necessitate caution in extrapolating animal data to humans.
    • Further research is needed to fully elucidate interspecies variations in drug metabolism.

    More Related Videos

    System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis09:57

    System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

    Published on: April 5, 2017

    Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells09:15

    Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells

    Published on: July 18, 2019

    Related Concept Videos

    The Endoplasmic Reticulum01:43

    The Endoplasmic Reticulum

    The endoplasmic reticulum or ER makes up for more than half of the membranes in a cell and accounts for 10% of total cell volume. It is also the primary protein and lipid synthesis factory for most cell organelles, such as the Golgi apparatus, lysosomes, secretory vesicles, and the plasma membrane. Despite being the most extensive and functionally complex subcellular organelle, ER was the last to be discovered. After years of deliberation, Keith Porter and George Palade in the year 1954,...
    Smooth Endoplasmic Reticulum01:21

    Smooth Endoplasmic Reticulum

    Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
    The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
    Directing Proteins to the Rough Endoplasmic Reticulum01:34

    Directing Proteins to the Rough Endoplasmic Reticulum

    The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
    Protein Modifications in the RER01:26

    Protein Modifications in the RER

    Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
    Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
    Post-translational Translocation of Proteins to the RER01:27

    Post-translational Translocation of Proteins to the RER

    A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
    Targeting proteins to the ER
    Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...